BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34168152)

  • 1. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
    Lu J; Ding Y; Chen Y; Jiang J; Chen Y; Huang Y; Wu M; Li C; Kong M; Zhao W; Wang H; Zhang J; Li Z; Lu Y; Yu X; Jin K; Zhou D; Zhou T; Teng F; Zhang H; Zhou Z; Wang H; Teng L
    Nat Commun; 2021 Jun; 12(1):3946. PubMed ID: 34168152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
    Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
    APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
    He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
    Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.
    Li XD; Wu CP; Ji M; Wu J; Lu B; Shi HB; Jiang JT
    World J Surg Oncol; 2013 Oct; 11():246. PubMed ID: 24083471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
    Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
    Zuo CT; Ju Q
    Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
    Wang R; Li J; Xu D; Li R; Gong P
    Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
    Gong W; Su Y; Liu A; Liu J; Sun D; Jiang T; Xiang J; Chi C; Sun P
    Neoplasma; 2018 Mar; 65(3):326-330. PubMed ID: 29788728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of persistent activity of the mammalian target of rapamycin pathway in the cisplatin resistance of AFP-producing gastric cancer cells.
    Kamata S; Kishimoto T; Kobayashi S; Miyazaki M; Ishikura H
    Cancer Biol Ther; 2007 Jul; 6(7):1036-43. PubMed ID: 17568186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
    Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
    Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.
    Mei Y; Li M; Wen J; Kong X; Li J
    Cancer Med; 2023 May; 12(10):12018-12033. PubMed ID: 37017469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
    Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of apoptosis by miR‑122‑5p in α‑fetoprotein‑producing gastric cancer.
    Maruyama S; Furuya S; Shiraishi K; Shimizu H; Saito R; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
    Oncol Rep; 2019 Apr; 41(4):2595-2600. PubMed ID: 30816512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.
    Jia Y; Liu D; Xiao D; Ma X; Han S; Zheng Y; Sun S; Zhang M; Gao H; Cui X; Wang Y
    PLoS One; 2013; 8(1):e54774. PubMed ID: 23382965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
    Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
    Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
    Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
    Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
    Chen E; Tang C; Peng K; Cheng X; Wei Y; Liu T
    Pathol Res Pract; 2019 Aug; 215(8):152454. PubMed ID: 31146977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy.
    Chang YC; Nagasue N; Kohno H; Ohiwa K; Yamanoi A; Nakamura T
    Cancer; 1992 Feb; 69(4):872-7. PubMed ID: 1370917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.
    Noske A; Henricksen LA; LaFleur B; Zimmermann AK; Tubbs A; Singh S; Storz M; Fink D; Moch H
    Exp Mol Pathol; 2015 Feb; 98(1):47-54. PubMed ID: 25527175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
    Deng N; Goh LK; Wang H; Das K; Tao J; Tan IB; Zhang S; Lee M; Wu J; Lim KH; Lei Z; Goh G; Lim QY; Tan AL; Sin Poh DY; Riahi S; Bell S; Shi MM; Linnartz R; Zhu F; Yeoh KG; Toh HC; Yong WP; Cheong HC; Rha SY; Boussioutas A; Grabsch H; Rozen S; Tan P
    Gut; 2012 May; 61(5):673-84. PubMed ID: 22315472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.